Status:
UNKNOWN
Effects of Neuromuscular Electrical Stimulation in Muscle Architecture and Functionality of Patients After Acute Stroke
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Stroke, Acute
Neuromuscular Electrical Stimulation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Introduction: Stroke is a sudden illness, responsible for important neurological and cognitive sequelae that can result in functional limitations and dependence. It is the leading cause of neurologica...
Detailed Description
Stroke is the leading cause of neurological impairment in young adults, and early rehabilitation is essential for the recovery of these patients. It is already known that muscle loss is one of the ma...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ischemic or hemorrhagic stroke performed by a neurologist based on clinical and neuroimaging characteristics;
- To present motor sequelae in the lower limb due to stroke.
Exclusion
- Previous motor deficits
- Complete recovery of motor deficits before the initial evaluation;
- Conditions that prevent neuromuscular electrical stimulation such as skin lesions at the site of electrode placement, pacemaker and therapy intolerance.
- Time greater than 72 hours since hospitalization.
Key Trial Info
Start Date :
August 30 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03840954
Start Date
August 30 2019
End Date
August 30 2022
Last Update
July 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HCPA
Porto Alegre, Rio Grande do Sul, Brazil, 90035903